Management of Normalized Menstrual Bleeding with LNG-IUS
Continue the levonorgestrel-releasing intrauterine system without any changes, as normalization of bleeding is the expected therapeutic outcome and indicates successful treatment. 1
Expected Bleeding Pattern Evolution
Approximately 50% of levonorgestrel-IUD users achieve amenorrhea or oligomenorrhea within two years of insertion, effectively eliminating heavy menstrual bleeding—this is the desired therapeutic endpoint, not a complication requiring intervention. 1
The transition from initial irregular bleeding to normalized or absent menses represents successful endometrial suppression and should be explained to patients as a positive treatment response rather than a concerning side effect. 2, 3
After 6 months of LNG-IUS use, 20% of women become amenorrheic, rising to 50% after 5 years—this "bleed-free" status is not related to hypothalamic-pituitary-ovarian axis dysfunction and should be viewed as a beneficial feature. 2
No Routine Follow-Up Required
Routine follow-up visits are not required after LNG-IUD placement when bleeding has normalized; patients should return only for concerning symptoms, side-effect discussions, or method change. 1
Routine IUD string checks at every visit are unnecessary—follow-up should be limited to specific patient concerns rather than scheduled surveillance. 1
Device Longevity and Continuation
The LNG-IUD can remain in place for 5–8 years depending on the specific device model, after which removal or replacement is advised. 1
The therapeutic effect of menstrual blood loss reduction is maintained for more than 5 years after initial placement in the uterine cavity. 4
Continuation rates for the LNG-IUS are high (46.9% at 5 years in large trials), with significantly fewer withdrawals due to bleeding problems compared to copper IUDs. 3
Critical Counseling Point
The absence of bleeding or minimal bleeding after initial LNG-IUS placement is an expected therapeutic outcome, not a complication—patients should have been counseled about this anticipated pattern before insertion to prevent unnecessary discontinuation. 1, 2
Detailed pre-insertion counseling about expected bleeding changes is crucial to reduce unnecessary discontinuation of treatment when patients experience the desired therapeutic effect of reduced or absent menses. 2
When to Intervene
The LNG-IUS should not be removed solely because of changes in bleeding pattern, including amenorrhea, as this represents successful treatment rather than method failure. 1
Intervention is only warranted if the patient develops new concerning symptoms such as pelvic pain, signs of infection, IUD displacement, or desires device removal for personal reasons—not for normalized bleeding alone. 1